20th Dec 2010 11:06
AGI Therapeutics PLC
Board Change
December 20th, 2010. AGI Therapeutics plc ("AGI" or the "Company) announces that David Young, a non-executive Director of the Company, will resign from the Board effective December 31st, 2010.
David was formerly Executive Director & President, US Operations of AGI up until October 2009. He is currently Chief Scientific Officer of Questcor Inc.
Ronan Lambe, AGI's Non Executive Chairman commented;
"On behalf of the board and shareholders, I would like to thank David for the time and energy he has given to AGI and wish him every success for the future."
Contact Information:
AGI Therapeutics plc. | Tel: +353 1 449 3254 |
David Kelly, Chief Financial Officer | |
Davy John Frain | Tel: +353 1 679 6363 |
Related Shares:
Potentially Ai